Digital biomanufacturing involves the digital technologies to improve the manufacturing process. It helps to enhanced the biological manufacturing by using computer aided design, verification and manufacture.
The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% during the forecast period (2022-2030).
Figure 1. Global Digital Biomanufacturing Market, in Terms of Value (US$ Billion), By Region, 2022
Global Digital Biomanufacturing Market: Drivers
Emerging role of digital biomanufacturing is expected to drive the global market growth during the forecast period.
Digital biomanufacturing addresses unique aspects of biological activities and increase the data collection, monitoring, process control algorithms, automation, etc. Advances such as artificial intelligence (AI), automation, and robotics, are changing concepts of manufacturing in general from product development and factory operations to materials supply. Thus, emerging implementation of smart manufacturing in bio-based industries is likely boost the market growth in near future.
|Base Year:||2021||Market Size in 2022:||US$ 17.92 Bn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||9.9%||2030 Value Projection:||US$ 38.14 Bn|
3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences
|Restraints & Challenges:||
Figure 2. Global Digital Biomanufacturing Market Share (%), By Type, 2022
Expansion of digital biomanufacturing plants is expected to drive the global market growth over the forecast period
Key players are increasing their focus on expand the manufacturing process with innovative technologies to improve production process with research and development, paving the way for improved commercialization of important new medicines for patients . This in turn to drive the growth of market. For instance, in October 2019, Sanofi, a global biopharmaceutical company opened its first digitally enabled continuous manufacturing facility in Framingham, Massachusetts.
Global Digital Biomanufacturing Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the pandemic. Thus, surge in adoption of digital technologies in biopharma sector during the pandemic is leads to boosting the demand for digital bioprocessing and thereby drive the growth of market.
Global Digital Biomanufacturing Market: Restraints
Lack of awareness regarding the technologically advanced services in emerging countries are the factors that are likely to hamper the growth of market.
Major players operating in the global digital biomanufacturing market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences
Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability. Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.
Advantages of digital manufacturing includes:
Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies. Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs. This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation. Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT), artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing. Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future
Key features of the study:
*” marked represents similar segmentation in other categories in the respective section.